Brain and central nervous system cancer: clinical quality performance indicators - engagement document

Guidance to our consultation on brain and central nervous system cancer clinical quality performance indicators which is taking place in January and February 2024.


7. Survival

Improving survival forms an integral part of the National Cancer Quality Programme. Brain/CNS cancer survival analysis will be reported and analysed on a 3 yearly basis by Public Health Scotland (PHS). The specific issues which will be addressed will be identified by an expert group ahead of any analysis being undertaken, as per the agreed national cancer quality governance and improvement framework.

The Brain/CNS Cancer QPI Group has identified the following issues for survival analysis:

  • 5 and 10 year overall survival

To ensure consistent application of survival analysis, it has been agreed that a single analyst on behalf of all three regional cancer networks undertakes this work. Survival analysis is scheduled as per the national survival analysis and reporting timetable, agreed with the National Cancer Quality Steering Group and Scottish Cancer Strategic Board. This reflects the requirement for record linkage and the more technical requirements of survival analyses which makes it difficult for individual Boards to undertake routinely and in a nationally consistent manner.

Contact

Email: cancerpolicyteam@gov.scot

Back to top